IXALTIS has been created by renowned urology and pharmaceutical experts : Dr Philippe Lluel, Christian Chavy, Stefano Palea, Dr Roberto Gradnik and Professors Pascal Rischmann and Xavier Gamé.

The vision of IXALTIS is to develop treatments for diseases of the genito-urinary tract where there is still a high-unmet medical need. This will be achieved by developing the molecules we have already in our portfolio and searching for other drugs which have already reached clinical stage, in a different indication, to be potentially repurposed.

IXALTIS has been created to develop and eventually market these compounds alongside further products to be acquired through licensing/acquisition in the genitourinary sphere.